Intech Biopharm Financials
| 6461 Stock | TWD 28.00 0.65 2.27% |
Intech |
Understanding current and past Intech Biopharm Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Intech Biopharm's financial statements are interrelated, with each one affecting the others. For example, an increase in Intech Biopharm's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Intech Biopharm's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Intech Biopharm. Check Intech Biopharm's Beneish M Score to see the likelihood of Intech Biopharm's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0006461007 |
| Business Address | No 36, Ruiguang |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.intechbiopharm.com |
| Phone | 886 2 7721 8877 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Intech Biopharm without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Intech Stock, because this is throwing your money away. Analyzing the key information contained in Intech Biopharm's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Intech Biopharm Key Financial Ratios
There are many critical financial ratios that Intech Biopharm's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Intech Biopharm reports annually and quarterly.| Return On Equity | -0.28 | |||
| Return On Asset | -0.0739 | |||
| Number Of Employees | 87 | |||
| Beta | 0.59 | |||
| Z Score | 1.8 |
Intech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intech Biopharm's current stock value. Our valuation model uses many indicators to compare Intech Biopharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intech Biopharm competition to find correlations between indicators driving Intech Biopharm's intrinsic value. More Info.Intech Biopharm is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intech Biopharm's earnings, one of the primary drivers of an investment's value.Intech Biopharm Systematic Risk
Intech Biopharm's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Intech Biopharm volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Intech Biopharm correlated with the market. If Beta is less than 0 Intech Biopharm generally moves in the opposite direction as compared to the market. If Intech Biopharm Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Intech Biopharm is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Intech Biopharm is generally in the same direction as the market. If Beta > 1 Intech Biopharm moves generally in the same direction as, but more than the movement of the benchmark.
Intech Biopharm December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Intech Biopharm help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intech Biopharm. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intech Biopharm based on widely used predictive technical indicators. In general, we focus on analyzing Intech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intech Biopharm's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 4.77 | |||
| Value At Risk | (1.83) | |||
| Potential Upside | 2.03 |
Additional Tools for Intech Stock Analysis
When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.